Biomodics - innovating to fight hospital infections

Biomodics is an innovative Danish company focusing on bringing to market medical devices that can prevent hospital acquired infections. Biomodics started as a spinout from the large Danish technological company NKT in 2009. Located at the Danish Technology Institute near Copenhagen, Denmark, the company has built up a strong patent portfolio of new technologies with great promise in the development of new biofilm-resistant medical devices able to prevent the all too frequent hospital acquired infections. Another focus area for the company is the development of innovative drug delivery solutions. Biomodics also specialises in processes using supercritical CO2 such as purification, extraction, and sterilization.

The first Foley catheter featuring IPN technology to stop CAUTI and help patients avoid unnecessary suffering

Our mission

We believe that healthcare associated infections can be almost eliminated. We want to end unnecessary illness and suffering of patients by bringing to market new and innovative medical devices that will help patients get better rather than make them suffer. Avoiding infections in hospitals saves lives and frees up resources.

Meet our team

Peter ThomsenCEO
Martin AlmHead of Polymers
PhD, MSc. Chemistry
Christian Heebøll-NielsenBusiness developer
MSc pharm
Yiqiang YANGScientific Assistant
Chemical Engineer

Our partners

Odense University Hospital
DTU Nanotech
Teknologisk Institut
Sydvestjysk Sygehus
Aarhus University

Find us on google map

Latest news

2016-20-05 Enterprise Europe on Biomodics

Enterprise Europe writes about Biomodics' Eurostar project with Zymetech and Teknologisk Institut. (in Danish) Link to article.

5.12.2016 Biomodics in Medwatch

Biomodics was featured in todays' Medwatch

5.8.2016 Biomed

Biomodics will participate in the Biomed conference in Tel Aviv, Israel May 24.26.